These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17012696)

  • 21. An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study.
    Chou YH; Chiu NM; Yang TT; Feng J; Chan CC; Lee HK;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):255-60. PubMed ID: 23820333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?
    Baune BT; Hohoff C; Roehrs T; Deckert J; Arolt V; Domschke K
    Neurosci Lett; 2008 May; 436(2):111-5. PubMed ID: 18387740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of serotonin-related gene polymorphisms on pathogenesis and treatment response in Korean schizophrenic patients.
    Kim YK; Yoon HK
    Behav Genet; 2011 Sep; 41(5):709-15. PubMed ID: 21399903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Depressive symptoms in schizophrenia].
    Gerard A
    Encephale; 1998 Jul; 24 Spec No 1():24-6. PubMed ID: 9809250
    [No Abstract]   [Full Text] [Related]  

  • 26. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series.
    Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT
    Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine.
    Bosia M; Lorenzi C; Pirovano A; Guglielmino C; Cocchi F; Spangaro M; Bramanti P; Smeraldi E; Cavallaro R
    Pharmacogenomics; 2015 Jan; 16(1):35-44. PubMed ID: 25560469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis.
    Takekita Y; Fabbri C; Kato M; Koshikawa Y; Tajika A; Kinoshita T; Serretti A
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26568455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 5-HT1A-receptor functional polymorphism on Theory of Mind performances in schizophrenia.
    Bosia M; Anselmetti S; Bechi M; Lorenzi C; Pirovano A; Cocchi F; Buonocore M; Bramanti P; Smeraldi E; Cavallaro R
    Psychiatry Res; 2011 Jul; 188(2):187-90. PubMed ID: 21194755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome.
    Malaspina D; Goetz RR; Yale S; Berman A; Friedman JH; Tremeau F; Printz D; Amador X; Johnson J; Brown A; Gorman JM
    Am J Psychiatry; 2000 Jun; 157(6):994-1003. PubMed ID: 10831482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antipsychotic withdrawal on negative symptoms in schizophrenia.
    Miller DD; Flaum M; Arndt S; Fleming F; Andreasen NC
    Neuropsychopharmacology; 1994 Aug; 11(1):11-20. PubMed ID: 7945739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.
    Robinson DG; Woerner MG; Alvir JM; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Bilder R; Goldman R; Lieberman JA
    Am J Psychiatry; 1999 Apr; 156(4):544-9. PubMed ID: 10200732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antidepressant treatment of schizophrenic patients].
    Caroli F; Baldacci-Epinette C; Ribeyre P
    Encephale; 1993 Jul; 19 Spec No 2():393-6. PubMed ID: 7904237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
    Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T
    Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain.
    Reynolds GP; Zhang Z; Zhang X
    Am J Psychiatry; 2003 Apr; 160(4):677-9. PubMed ID: 12668355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone.
    Frankle WG; Lombardo I; Kegeles LS; Slifstein M; Martin JH; Huang Y; Hwang DR; Reich E; Cangiano C; Gil R; Abi-Dargham A; Laruelle M
    J Psychopharmacol; 2011 Jun; 25(6):734-43. PubMed ID: 21109614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression in patients with schizophrenia during an acute psychotic episode.
    Tapp A; Kilzieh N; Wood AE; Raskind M; Tandon R
    Compr Psychiatry; 2001; 42(4):314-8. PubMed ID: 11458306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.
    Takekita Y; Fabbri C; Kato M; Nonen S; Sakai S; Sunada N; Koshikawa Y; Wakeno M; Okugawa G; Kinoshita T; Serretti A
    J Clin Psychopharmacol; 2015 Jun; 35(3):220-7. PubMed ID: 25822479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.